戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 responses are impaired in most patients with common variable immunodeficiency.
2 ession is similarly decreased in humans with common variable immunodeficiency.
3 ere, primary immunodeficiency reminiscent of common variable immunodeficiency.
4 ment similar to those found in patients with common variable immunodeficiency.
5 phoproliferative disease and severe cases of common variable immunodeficiency.
6 efects in patients previously diagnosed with common variable immunodeficiency.
7 ar antibodies, sinopulmonary infections, and common variable immunodeficiency.
8 ve been found to be mutated in patients with common variable immunodeficiency.
9 rom a poliomyelitis patient from Taiwan with common variable immunodeficiency.
10 est risk was associated with T-cell PIDs and common variable immunodeficiency.
11 fferentiation in familial IgA deficiency and common variable immunodeficiency.
12 tions in LRBA Biallelic LRBA mutations cause common variable immunodeficiency-8; however, NDM has not
13  was highly similar to that of patients with common variable immunodeficiency and a defect in B-cell
14 ilin ligand interactor (TACI), contribute to common variable immunodeficiency and autoimmunity in hum
15 on, shown through the study of patients with common variable immunodeficiency and hyper IgM syndrome,
16 ustrate the heterogeneous molecular basis of common variable immunodeficiency and indicate the value
17 is review discusses the latest insights into common variable immunodeficiency and uses common variabl
18 everal primary immunodeficiencies, including common variable immunodeficiency and Wiskott-Aldrich syn
19        In humoral immunodeficiencies such as common variable immunodeficiency and X-linked agammaglob
20 and additional family members suffering from common variable immunodeficiency and/or selective IgA de
21 n a clinical picture that is consistent with common variable immunodeficiency, and as many as 10% of
22 orders such as systemic lupus erythematosus, common variable immunodeficiency, and autoimmune lymphop
23 to common variable immunodeficiency and uses common variable immunodeficiency as a model to examine t
24                                Patients with common variable immunodeficiency can be chronically infe
25 ound that 4 of 19 unrelated individuals with common variable immunodeficiency (CVID) and 1 of 16 indi
26                            Patients who have common variable immunodeficiency (CVID) and granulomatou
27              The population of patients with common variable immunodeficiency (CVID) comprises a hete
28                     B cells of patients with common variable immunodeficiency (CVID) disorders displa
29                  A subgroup of patients with common variable immunodeficiency (CVID) experience immun
30 ma cells, and almost 10% of individuals with common variable immunodeficiency (CVID) express either t
31                                     Although common variable immunodeficiency (CVID) has long been co
32                    A subset of patients with common variable immunodeficiency (CVID) have debilitatin
33                                              Common variable immunodeficiency (CVID) is a disease tha
34                                              Common variable immunodeficiency (CVID) is a heterogeneo
35                                              Common variable immunodeficiency (CVID) is a heterogeneo
36                                              Common variable immunodeficiency (CVID) is a heterogeneo
37                                              Common variable immunodeficiency (CVID) is a syndrome ch
38                                              Common variable immunodeficiency (CVID) is an antibody d
39                                              Common variable immunodeficiency (CVID) is an antibody d
40                                              Common variable immunodeficiency (CVID) is an immune dis
41                                              Common variable immunodeficiency (CVID) is characterized
42                                              Common variable immunodeficiency (CVID) is characterized
43                                              Common variable immunodeficiency (CVID) is the commonest
44                                              Common variable immunodeficiency (CVID) is the primary i
45                                              Common variable immunodeficiency (CVID) patients can dev
46                                A subgroup of common variable immunodeficiency (CVID) patients have di
47  in patients with autoimmune diseases and in common variable immunodeficiency (CVID) patients who are
48                                 B cells from common variable immunodeficiency (CVID) patients who hav
49                           Most patients with common variable immunodeficiency (CVID) present with sev
50 the HVR of control patients to patients with common variable immunodeficiency (CVID) where the effect
51                   B cells from patients with common variable immunodeficiency (CVID) who are heterozy
52 arisons between patients with GS, those with common variable immunodeficiency (CVID), and those with
53                                              Common variable immunodeficiency (CVID), characterized b
54 ts with multilineage cytopenias secondary to common variable immunodeficiency (CVID), Evans syndrome
55 al profile of CD4 T cells from patients with common variable immunodeficiency (CVID), including produ
56                                              Common variable immunodeficiency (CVID), the most freque
57 or PAD syndromes, with a particular focus on common variable immunodeficiency (CVID).
58 sess the genetic background of patients with common variable immunodeficiency (CVID).
59  lymphoid hyperplasia (PLH) in patients with common variable immunodeficiency (CVID).
60            Our index case was a patient with common variable immunodeficiency (CVID).
61 ACI) are found in 8% to 10% of subjects with common variable immunodeficiency (CVID).
62 s in these 2 genes have been associated with common variable immunodeficiency (CVID).
63 also been identified in some cases of severe common variable immunodeficiency disease.
64                                              Common variable immunodeficiency disorder (CVID) is the
65 le nucleotide polymorphisms in patients with common variable immunodeficiency disorder (CVID), which
66 mplex polygenic disorders, most commonly the common variable immunodeficiency disorders (CVIDs), pred
67                                 The European Common Variable Immunodeficiency Disorders registry was
68                  Both Sjogren's syndrome and common variable immunodeficiency display clinical and im
69 ysis of the proportion of any combination of common variable immunodeficiency, IgG deficiency, IgA de
70 -telangiectasia, Nijmegen-breakage-syndrome, common variable immunodeficiency, immunoglobulin A defic
71          Biallelic CD19 gene mutations cause common variable immunodeficiency in human subjects.
72                                              Common variable immunodeficiency is a rare immune defici
73                                              Common variable immunodeficiency is the most common prim
74 s human PRKCD deficiency as a novel cause of common variable immunodeficiency-like B-cell deficiency
75 e defects affect a minority of patients with common variable immunodeficiency only, future genetic re
76 tterns in gut biopsies from individuals with common variable immunodeficiency or with HIV infection a
77      Using these assays, we could categorize common variable immunodeficiency patients into subgroups
78 children <2 y, the asplenic, and a subset of common variable immunodeficiency patients, are profoundl
79 rated IRF4 to be deregulated in B cells from common variable immunodeficiency patients, contributing
80 rstand the defective functions of B cells in common variable immunodeficiency patients.
81 reasons for an increased risk of lymphoma in common variable immunodeficiency patients.
82 tic assessment in paediatric patients with a common variable immunodeficiency phenotype, to establish
83 t activity might produce Omenn syndrome or a common variable immunodeficiency phenotype.
84    Newly identified disease genes within the common variable immunodeficiency population, have advanc
85                                              Common variable immunodeficiency represents the largest
86 present the different clinical phenotypes of common variable immunodeficiency, review recent genetic
87 ith unusually frequent bacterial infections, common variable immunodeficiency should always be consid
88 day period from a poliomyelitis patient with common variable immunodeficiency syndrome (a defect in a
89 t poliovirus infection in an individual with common variable immunodeficiency, using oral immunoglobu
90 ional features not typically associated with common variable immunodeficiency were diagnosed only lat
91 pecific antibody deficiencies; and potential common variable immunodeficiency), were retrieved.
92 nted with a phenotype resembling early-onset common variable immunodeficiency, while extra-immunologi
93       A 44-year-old woman with long-standing common variable immunodeficiency who was receiving intra
94 hich was previously implicated as a cause of common variable immunodeficiency with autoimmunity.
95 the diagnosis and treatment of patients with common variable immunodeficiency, with suggestions for t

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。